CS logo
small CS logo
University of Luebeck

Luebeck, Germany
Public university in Lübeck, Schleswig-Holstein
Ratzeburger Allee 160, 23562 Lübeck

About University of Luebeck


The University of Lübeck is a research university in Lübeck, Northern Germany which focuses almost entirely on medicine and sciences with applications in medicine.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
University of Luebeck
7
University Hospital Schleswig-Holstein
4
Prof. Dr. med. Ingo Eitel
3
Charite University, Berlin, Germany
2
Drägerwerk AG & Co. KGaA
2
Pfizer
2
IVERIC bio, Inc.
1
Leipzig Heart Institute GmbH
1
Michael J. Fox Foundation for Parkinson's Research
1
Stryker Neurovascular
1
University Hospital Tuebingen
1
Total Rows: 12

Clinical Trials at University of Luebeck


During the past decade, University of Luebeck conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 3 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 1 clinical trials were completed. i.e. 7.7% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years33551111115566220000111100110000Started TrialsCompleted Trails2015201620172018201920202021202202468
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Effects of Transfusion Thresholds on Neurocognitive Outcome of Extremely Low Birth Weight Infants
2011-07-01
2018-10-31
Completed
1,013
Randomized, Placebo Controlled Study Of The Efficacy And Safety Of PF-02545920 In Subjects With Huntington's Disease
2014-09-01
2016-10-01
Completed
272
Open Label Extension Study To Investigate Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Completed Study A8241021
2015-02-25
2017-02-06
Terminated
188
Impact of Morphine Treatment on Platelet Inhibition in Acute Myocardial Infarction
2015-12-01
2018-10-01
Completed
138
EverolimuS-ElUtinG BioresorbAble VasculaR Scaffolds vErsus EVerolimus-Eluting Stents in Patients With Diabetes Mellitus
2016-01-01
2017-01-03
Terminated
33
SecOnd-generation seLf-expandable Versus Balloon-expandable Valves and gEneral Versus Local Anesthesia in TAVI
2016-04-01
2021-04-01
Unknown status
444
Bioresorbable Vascular Scaffolds Versus Stents in Patients With Chronic Total Occlusion
2016-09-01
2017-01-01
Terminated
17
Glycoprotein IIb/IIIa Inhibitors Versus Standard Therapy in Patients With Myocardial Infarction and No-reflow
2016-07-01
2020-08-01
Unknown status
120

Rows per page:

1–26 of 26

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "University of Luebeck" #1 sponsor was "University of Luebeck" with 7 trials, followed by "University Hospital Schleswig-Holstein" with 4 trials sponsored, "Prof. Dr. med. Ingo Eitel" with 3 trials sponsored, "Charite University, Berlin, Germany" with 2 trials sponsored and "Drägerwerk AG & Co. KGaA" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 12 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "University of Luebeck" #1 collaborator was "Charite University, Berlin, Germany" with 3 trials as a collaborator, "German Research Foundation" with 2 trials as a collaborator, "Zealand University Hospital" with 2 trials as a collaborator, "BARMER" with 1 trials as a collaborator and "Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)" with 1 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 24 trials.
Created with Highcharts 11.1.0Top Leading SponsorsUniversity of Luebeck: 7University of Luebeck: 7University HospitalSchleswig-Holstein: 4University HospitalSchleswig-Holstein: 4Prof. Dr. med. Ingo Eitel: 3Prof. Dr. med. Ingo Eitel: 3Charite University,Berlin, Germany: 2Charite University,Berlin, Germany: 2Drägerwerk AG & Co. KGaA: 2Drägerwerk AG & Co. KGaA: 2Pfizer: 2Pfizer: 2IVERIC bio, Inc.: 1IVERIC bio, Inc.: 1Leipzig Heart Institute GmbH: 1Leipzig Heart Institute GmbH: 1Michael J. FoxFoundation forParkinson's Research: 1Michael J. FoxFoundation forParkinson's Research: 1Stryker Neurovascular: 1Stryker Neurovascular: 1

Created with Highcharts 11.1.0Top CollaboratorsCharite University,Berlin, Germany: 3Charite University,Berlin, Germany: 3German Research Foundation: 2German Research Foundation: 2Zealand University Hospital: 2Zealand University Hospital: 2BARMER: 1BARMER: 1Deutsches Zentrum fürHerz-Kreislauf-Forschung (DZHK): 1Deutsches Zentrum fürHerz-Kreislauf-Forschung (DZHK): 1Hannover Medical School: 1Hannover Medical School: 1Heart Center Leipzig -University Hospital: 1Heart Center Leipzig -University Hospital: 1Institute forNeurodegenerativeDisorders: 1Institute forNeurodegenerativeDisorders: 1Kerckhoff Klinik: 1Kerckhoff Klinik: 1Klinikum Links derWeser Bremen: 1Klinikum Links derWeser Bremen: 1

Clinical Trials Conditions at University of Luebeck


According to Clinical.Site data, the most researched conditions in "University of Luebeck" are "Acute Myocardial Infarction" (2 trials), "Coronary Artery Disease" (2 trials), "Huntington's Disease" (2 trials), "Infertility" (2 trials) and "Spinal Cord Compression Due to Metastasis to Spine" (2 trials). Many other conditions were trialed in "University of Luebeck" in a lesser frequency.

Clinical Trials Intervention Types at University of Luebeck


Most popular intervention types in "University of Luebeck" are "Drug" (7 trials), "Other" (6 trials), "Device" (5 trials), "Behavioral" (3 trials) and "Diagnostic Test" (3 trials). Other intervention types were less common.
The name of intervention was led by "Prehabilitation- new form of care" (2 trials), "20 mg BID of PF-02545920" (1 trials), "Absorb GT1" (1 trials), "Blood samples and microbiological swaps" (1 trials) and "CoreValve Evolut R" (1 trials). Other intervention names were less common.

Clinical Trials Genders at University of Luebeck


The vast majority of trials in "University of Luebeck" are 24 trials for "All" genders and 2 trials for "Female" genders.

Clinical Trials Status at University of Luebeck


Currently, there are 13 active trials in "University of Luebeck". 1 are not yet recruiting, 10 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 6 completed trials in University of Luebeck, undefined suspended trials, and 3 terminated clinical trials to date.
Out of the total trials that were conducted in University of Luebeck, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 12 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhaseNot Applicable: 12Not Applicable: 12Phase 4: 3Phase 4: 3Phase 2: 2Phase 2: 2Phase 3: 1Phase 3: 1

Created with Highcharts 11.1.0Trials StatusRecruiting: 10Recruiting: 10Completed: 6Completed: 6Unknown status: 4Unknown status: 4Terminated: 3Terminated: 3Active, not recruiting: 1Active, not recruiting: 1Enrolling by invitation: 1Enrolling by invitation: 1Not yet recruiting: 1Not yet recruiting: 1

Departments of University of Luebeck


University of Luebeck has several departments that took part in Clinical trials: "Department of Radiation Oncology, University of Lübeck and University Medical Center Schleswig-Holstein" - 11 trials, "Department of Dermatology, University of Lübeck" - 2 trials, "University of Luebeck, Dept. of Neurology" - 2 trials